Ahmed, M., and Lyles, D.S. (1998). Effect of Vesicular Stomatitis Virus Matrix Protein on Transcription Directed by Host RNA Polymerases I, II, and III. J. Virol. 72, 8413-8419.
Ahmed, M., McKenzie, M.O., Puckett, S., Hojnacki, M., Poliąuin, L., and Lyles, D.S. (2003). Ability of the Matrix Protein of Vesicular Stomatitis Virus To Suppress Beta Interferon Gene Expression Is Genetically Correlated with the Inhibition of Host RNA and Protein Synthesis. J. Virol. 77, 4646-4657.
Ahmed, M., Mitchell, L.M., Puckett, S., Brzoza-Lewis, K.L., Lyles, D.S., and Hiltbold, E M. (2009). Vesicular stomatitis virus M protein mutant stimulates maturation of Toll-like receptor 7 (TLR7)-positive dendritic cells through TLR-dependent and -independent mechanisms. J. Virol. 83,2962-2975.
Balachandran, S., and Barber, G.N. (2000). Vesicu!ar stomatitis virus (VSV) therapy of tumors. IUBMB Life 50, 135-138.
Balachandran, S., and Barber, G.N. (2004). Defective translational control facilitates vesicular stomatitis virus oncolysis. Cancer Celi 5, 51-65.
Black, B.L., Rhodes, R.B., McKenzie, M., and Lyles, D.S. (1993). The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable ffom its function in virus assembly. J. Virol. 67,4814-4821.
Bordoli, L., Kiefer, F., Arnold, K., Benkert, P., Battey, J., and Schwede, T. (2008). Protein structure homology modeling using SWISS-MODEL workspace. Nat. Protocols 4, 1-13.
Braxton, C.L., Puckett, S.H., Mizel, S.B., and Lyles, D.S. (2010). Protection against Lethal Vaccinia Virus Challenge by Using an Attenuated Matrix Protein Mutant Vesicular Stomatitis Virus Vaccine Vector Expressing Poxvirus Antigens. J. Virol. 84, 3552-3561.
Cobleigh, M.A., Buonocore, L., Uprichard, S.L., Rosę, J.K., and Robek, M.D. (2010) A Vesicular Stomatitis Virus-Based Hepatitis B Virus Vaccine Vector Provides Protection against Challenge in a Single Dose. J. Yirol. 84, 7513-7522.